Rajiv Malik

Mylan to invest $1 billion in India on capex in six years

Read more

Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting

Read more

Mylan launches Gilead Sciences’ Sovaldi tablets in India

Read more

Mylan signs exclusive agreement with Gilead Sciences

Read more

Mylan to acquire Famy Care to create women’s healthcare franchise

Read more